Specific inhibition of desmosterol synthesis by ML--236B in mouse LM cells grown in suspension in a lipid-free medium
- PMID: 732030
- DOI: 10.7883/yoken1952.31.225
Specific inhibition of desmosterol synthesis by ML--236B in mouse LM cells grown in suspension in a lipid-free medium
Abstract
The suspended growth of LM cells in a lipid-free chemically defined medium was almost completely inhibited in the presence of 0.1 microgram/ml of ML-236B, a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate limiting enzyme in cholesterol biosynthesis in mammalian cells. This inhibition was effectively counteracted by adding a small amount of either mevalonate or cholesterol (dispersed in delipidated calf serum) to culture medium. The synthesis of desmosterol, the end product of sterol biosynthesis in LM cells, from [14C]acetate in cultured cells was highly sensitive to ML-236B, being inhibited 35 and 60% at its concentrations of 0.1 and 1 ng/ml, respectively, while the incorporation of [3H]mevalonate into desmosterol was not affected by ML-236B at concentrations up to 0.1 microgram/ml. Synthesis of fatty acids, phospholipids, triglycerides and macromolecules like DNA, RNA and protein were not suppressed by 10 microgram/ml of ML-236B. Desmosterol content of LM cells was reduced by treatment with ML-236B. These results indicate that ML-236B inhibited cell growth via specific interference in the pathway of sterol biosynthesis, presumably on the step catalyzed by HMG-CoA reductase.
Similar articles
-
Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236B.Blood. 1983 Apr;61(4):667-71. Blood. 1983. PMID: 6831033
-
Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.Eur J Biochem. 1987 May 4;164(3):547-52. doi: 10.1111/j.1432-1033.1987.tb11161.x. Eur J Biochem. 1987. PMID: 3569277
-
Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.J Clin Invest. 1981 May;67(5):1532-40. doi: 10.1172/jci110184. J Clin Invest. 1981. PMID: 7229037 Free PMC article.
-
Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.Eur J Biochem. 1977 Jul 1;77(1):31-6. doi: 10.1111/j.1432-1033.1977.tb11637.x. Eur J Biochem. 1977. PMID: 908337 No abstract available.
-
Control of sterol metabolism in cultured rat granulosa cells.Endocrinology. 1981 Nov;109(5):1518-27. doi: 10.1210/endo-109-5-1518. Endocrinology. 1981. PMID: 7297489
Cited by
-
Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors.Klin Wochenschr. 1988 May 16;66(10):421-7. doi: 10.1007/BF01745510. Klin Wochenschr. 1988. PMID: 3294493 Review.
-
Changes in sterol biosynthesis accompanying cessation of glial cell growth in serum-free medium.Biochem J. 1980 Nov 15;192(2):709-17. doi: 10.1042/bj1920709. Biochem J. 1980. PMID: 7236234 Free PMC article.
-
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women.Pharmaceuticals (Basel). 2020 Nov 25;13(12):422. doi: 10.3390/ph13120422. Pharmaceuticals (Basel). 2020. PMID: 33255609 Free PMC article. Review.
-
Isoprenoids: remarkable diversity of form and function.Lipids. 2004 Apr;39(4):293-309. doi: 10.1007/s11745-004-1233-3. Lipids. 2004. PMID: 15357017 Review.
-
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proc Natl Acad Sci U S A. 1980 Jul;77(7):3957-61. doi: 10.1073/pnas.77.7.3957. Proc Natl Acad Sci U S A. 1980. PMID: 6933445 Free PMC article.